Skip to Main Content

Author Details

Jared R Tinklenberg
Stanford University School of Medicine, Stanford University
1970
171
45
PMIDPaper TitleJournal TitlePublished Year
31743997Factors Associated with Supportive Care Service Use Among California Alzheimer's Disease Patients and Their Caregivers.J Alzheimers Dis2020
25747405Donepezil treatment in ethnically diverse patients with Alzheimer disease.Am J Geriatr Psychiatry2015
22959822Walking stabilizes cognitive functioning in Alzheimer's disease (AD) across one year.Arch Gerontol Geriatr2013
23703151Memantine is associated with longer survival than donepezil in a Veterans Affairs prescription database, 1997 to 2008.J Alzheimers Dis2013
22343285Association of common genetic variants in GPCPD1 with scaling of visual cortical surface area in humans.Proc Natl Acad Sci U S A2012
21709609Circadian clock gene polymorphisms and sleep-wake disturbance in Alzheimer disease.Am J Geriatr Psychiatry2011
17974866Donepezil treatment and Alzheimer disease: can the results of randomized clinical trials be applied to Alzheimer disease patients in clinical practice?Am J Geriatr Psychiatry2007
19595924Statistical and pharmacoeconomic issues for Alzheimer's screening.Alzheimers Dement2007
17934472Classification and prediction of clinical Alzheimer's diagnosis based on plasma signaling proteins.Nat Med2007
16150458Factors in choosing atypical antipsychotics: toward understanding the bases of physicians' prescribing decisions.J Psychiatr Res2006
19595905Factors associated with use of medications with potential to impair cognition or cholinesterase inhibitors among Alzheimer's disease patients.Alzheimers Dement2006
16449758Spatial test for agricultural pesticide "blow-in" effect on prevalence of Parkinson's disease.J Geriatr Psychiatry Neurol2006
16627933The brain-derived neurotrophic factor Val66Met polymorphism and rate of decline in Alzheimer's disease.J Alzheimers Dis2006
16651505Caution regarding the use of pilot studies to guide power calculations for study proposals.Arch Gen Psychiatry2006
15681622Tolerability and effectiveness of lamotrigine in complex elderly patients.J Geriatr Psychiatry Neurol2005
15157348Validation of a 26-point telephone version of the Mini-Mental State Examination.J Geriatr Psychiatry Neurol2004
15018696Use of a VA pharmacy database to screen for areas at high risk for disease: Parkinson's disease and exposure to pesticides.J Geriatr Psychiatry Neurol2004
15018693Sleep/wake disruption in Alzheimer's disease: APOE status and longitudinal course.J Geriatr Psychiatry Neurol2004
14563385Age and disease severity predict choice of atypical neuroleptic: a signal detection approach to physicians' prescribing decisions.J Psychiatr Res2003
12094910Sleep/wake cycle disturbance in Alzheimer's disease: how much is due to an inherent trait?Int Psychogeriatr2002
12489920Which Alzheimer patients are at risk for rapid cognitive decline?J Geriatr Psychiatry Neurol2002
12468900On disentangling states versus traits: demonstration of a new technique using the Alzheimer's disease assessment scale.Alzheimer Dis Assoc Disord2002
12105320Donepezil and flight simulator performance: effects on retention of complex skills.Neurology2002
11402127Rate of cognitive decline in AD is accelerated by the interleukin-1 alpha -889 *1 allele.Neurology2001
11311039Remote memory for public figures in Alzheimer's disease: relationships to regional cortical and limbic brain volumes.J Int Neuropsychol Soc2001
11302364Event-related brain potential evidence of spared knowledge in Alzheimer's disease.Psychol Aging2001
10791866Extent, pattern, and correlates of remote memory impairment in Alzheimer's disease and Parkinson's disease.Neuropsychology2000
10910420A retrospective chart review of gabapentin for the treatment of aggressive and agitated behavior in patients with dementias.Am J Geriatr Psychiatry2000
10681076Clinical criteria for the diagnosis of vascular dementia: a multicenter study of comparability and interrater reliability.Arch Neurol2000
10674796Structural brain correlates of verbal and nonverbal fluency measures in Alzheimer's disease.Neuropsychology2000
10668709Alpha2 macroglobulin and the risk of Alzheimer's disease.Neurology2000
10751266Combined assessment of tau and neuronal thread protein in Alzheimer's disease CSF.Neurology2000
10561930Brain structural and cognitive correlates of clock drawing performance in Alzheimer's disease.J Int Neuropsychol Soc1999
10342806Taking account of between-patient variability when modeling decline in Alzheimer's disease.Am J Epidemiol1999
10650584Convergent behavioral and neuropsychological evidence for a distinction between identification and production forms of repetition priming.J Exp Psychol Gen1999
10527059Dissociation between two forms of conceptual priming in Alzheimer's disease.Neuropsychology1999
9769442The stages of Alzheimer's disease: a reappraisal.Dement Geriatr Cogn Disord1998
9673992Preserved priming across study-test picture transformations in patients with Alzheimer's disease.Neuropsychology1998
9629527Cognitive and noncognitive symptoms in dementia patients: relationship to cortisol and dehydroepiandrosterone.Int Psychogeriatr1998
9529820Structural MRI correlates of recognition memory in Alzheimer's disease.J Int Neuropsychol Soc1998
9686746A follow-up study of actigraphic measures in home-residing Alzheimer's disease patients.J Geriatr Psychiatry Neurol1998
9137113No association between apolipoprotein E epsilon 4 allele and rate of decline in Alzheimer's disease.Am J Psychiatry1997
9169250The apolipoprotein E epsilon 4 allele is associated with increased behavioral disturbance in Alzheimer's disease.Am J Geriatr Psychiatry1997
9258894Automatic and effortful processing in aging and dementia: event-related brain potentials.Neurobiol Aging1997
9153464No association between the alpha 1-antichymotrypsin A allele and Alzheimer's disease.Neurology1997
9193207Selective cortical and hippocampal volume correlates of Mattis Dementia Rating Scale in Alzheimer disease.Arch Neurol1997
9193203Cognitive function and the costs of Alzheimer disease. An exploratory study.Arch Neurol1997
9188020Disruptive behavior and actigraphic measures in home-dwelling patients with Alzheimer's disease: preliminary report.J Geriatr Psychiatry Neurol1997
8893133Neurointegrative role of dopamine and GABA in psychosis.Ann Pharmacother1996
8916107Rate of cognitive decline in Alzheimer's disease is not affected by the alpha-1-antichymotrypsin A allele or the CYP2D6 B mutant.Neurosci Lett1996
  • 1 - 50 of 171

Recommended Authors

Rita Khoury
Saint Louis University
Career Start Year 2009
Number of shared co-authors 0
Moon Ho Park
Korea University Ansan Hospital, Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 0
Jennifer S Hui
Keck School of Medicine of USC
Career Start Year 2001
Number of shared co-authors 2
Rodrigo A Bressan
Universidade Federal de Sao Paulo (UNIFESP), Brazil Instituto #amesuamente.
Career Start Year 1998
Number of shared co-authors 4
Steven D Edland
University of California San Diego
Career Start Year 1993
Number of shared co-authors 32
David S Geldmacher
University of Alabama at Birmingham
Career Start Year 1993
Number of shared co-authors 18
Robert A Sweet
University of Pittsburgh
Career Start Year 1990
Number of shared co-authors 21
Paul E Schulz
The University of Texas Health Science Center at Houston, McGovern Medical School
Career Start Year 1988
Number of shared co-authors 4
Carol A Manning
University of Virginia
Career Start Year 1988
Number of shared co-authors 8
Shahrokh Golshan
University of California
Career Start Year 1988
Number of shared co-authors 2
James D Bowen
Swedish Neuroscience Institute
Career Start Year 1987
Number of shared co-authors 49
Mark A Mandelkern
University of California at Irvine
Career Start Year 1986
Number of shared co-authors 6
Simon Lovestone
Janssen Medical Ltd
Career Start Year 1986
Number of shared co-authors 67
Bertram Krumm
Central Institute of Mental Health, University of Heidelberg
Career Start Year 1985
Number of shared co-authors 4
Laura J Fochtmann
Stony Brook University
Career Start Year 1979
Number of shared co-authors 3
Bruce M Cohen
Harvard Medical School
Career Start Year 1979
Number of shared co-authors 4
Jason Brandt
The Johns Hopkins University School of Medicine
Career Start Year 1979
Number of shared co-authors 18
Cameron G Swift
King's College London
Career Start Year 1978
Number of shared co-authors 0
Edythe D London
Brain Research Institute, University of California at Los Angeles
Career Start Year 1977
Number of shared co-authors 12
Eric B Larson
University of Washington
Career Start Year 1977
Number of shared co-authors 62
David S Knopman
Mayo Clinic Rochester
Career Start Year 1975
Number of shared co-authors 91
Joseph J Locascio
Harvard Medical School, Massachusetts General Hospital
Career Start Year 1975
Number of shared co-authors 9
William B Lawson
Howard University
Career Start Year 1974
Number of shared co-authors 12
Lindy E Harrell
University of Alabama at Birmingham
Career Start Year 1973
Number of shared co-authors 52
Igor Grant
University of California San Diego
Career Start Year 1973
Number of shared co-authors 11
Wolfgang Maier
University Hospital Bonn
Career Start Year 1972
Number of shared co-authors 63
Peter V Rabins
Johns Hopkins School of Medicine
Career Start Year 1971
Number of shared co-authors 19
Dilip V Jeste
Neurosciences University of California San Diego
Career Start Year 1969
Number of shared co-authors 17
Guy M McKhann
New York Presbyterian Hospital, Columbia University Medical Center
Career Start Year 1959
Number of shared co-authors 9
John I Nurnberger
Stark Neurosciences Research Institute, Indiana University School of Medicine
Career Start Year 1952
Number of shared co-authors 13

Collaborators

Jerome A Yesavage
Stanford University School of Medicine
Co-authored papers 79
Joy L Taylor
Stanford University
Co-authored papers 24
Leah Friedman
Stanford University
Co-authored papers 11
Ruth O'Hara
Stanford University School of Medicine
Co-authored papers 11
Laura Marsh
Co-authored papers 4
John D E Gabrieli
Massachusetts Institute of Technology
Co-authored papers 4
Philippe Frossard
Co-authored papers 4
William J Jagust
Helen Wills Neuroscience Institute, University of California Berkeley
Co-authored papers 3
Terry L Jernigan
Center for Human Development, University of California
Co-authored papers 3
Bruce L Miller
UCSF Weill Institute for Neurosciences, University of California san francisco
Co-authored papers 3
Martin R Farlow
Stark Neurosciences Research Institute, Indiana University School of Medicine (IUSM)
Co-authored papers 2
Kristine Yaffe
Weill Institute for Neurosciences and Departments of Psychiatry (KY)
Co-authored papers 2
Joseph F Quinn
Oregon Health and Science University
Co-authored papers 2
Douglas Galasko
Co-authored papers 2
Ann M Hake
Indiana University School of Medicine
Co-authored papers 2
Marwan N Sabbagh
Barrow Neurological Institute
Co-authored papers 2
Martin S Mumenthaler
Stanford University School of Medicine
Co-authored papers 2
Jeffrey Kaye
Oregon Center for Aging & Technology
Co-authored papers 2
Robert Bartha
The University of Western Ontario
Co-authored papers 1
Stanley Thomas Carmichael
David Geffen School of Medicine at University of California-Los Angeles
Co-authored papers 1
Hilda Rizzo-Busack
Co-authored papers 1
Ranjan Duara
Wien Center for Alzheimer's Disease and Memory Disorders, Mount Sinai Medical Center
Co-authored papers 1
Dana Mathews
University of Texas Southwestern Medical Center
Co-authored papers 1
Nancy Johnson
Northwestern University Feinberg School of Medicine
Co-authored papers 1
Sandra A Jacobson
University of Arizona College of Medicine
Co-authored papers 1
Smita Kittur
SUNY Upstate Medical University
Co-authored papers 1
Amber M Bailey
Co-authored papers 1
Andrew J Saykin
Indiana University School of Medicine
Co-authored papers 1
Richard Frank
Siemens Healthineers North America, Siemens Medical Solutions USA
Co-authored papers 1
Ging-Yuek
Co-authored papers 1
Release 1.2